SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-11-022463
Filing Date
2011-04-15
Accepted
2011-04-15 16:10:24
Documents
5
Effectiveness Date
2011-04-15

Document Format Files

Seq Description Document Type Size
1 v218756_defa14a.htm DEFA14A 26680
2 GRAPHIC image_1.jpg GRAPHIC 189426
3 GRAPHIC image_2.jpg GRAPHIC 237051
4 GRAPHIC image_3.jpg GRAPHIC 144755
5 GRAPHIC image_4.jpg GRAPHIC 96896
  Complete submission text file 0001144204-11-022463.txt   948788
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEFA14A | Act: 34 | File No.: 000-25169 | Film No.: 11762831
SIC: 2834 Pharmaceutical Preparations